Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-23T11:04:05.263Z Has data issue: false hasContentIssue false

Heart rate variability in children with acute rheumatic fever

Published online by Cambridge University Press:  21 September 2011

Mehmet Karacan
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine, Ataturk University, Erzurum, Turkey
Naci Ceviz*
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine, Ataturk University, Erzurum, Turkey
Haşim Olgun
Affiliation:
Division of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine, Ataturk University, Erzurum, Turkey
*
Correspondence to: Dr N. Ceviz, MD, Division of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine, Ataturk University, Erzurum, Turkey. Tel: +90 442 2312740; Fax: +90 442 2361301; E-mail: ceviznaci@yahoo.com

Abstract

Objective

Acute rheumatic fever is a systemic inflammatory disease occurring after acute streptococcal tonsillopharyngitis. The PR prolongation in these patients is thought to be due to increased vagal activity. There has been no previous study investigating the autonomic balance in patients with acute rheumatic fever. In this study, we aimed to investigate the balance of the autonomic nervous system in children with acute rheumatic fever by analysis of heart rate variability.

Methods

We evaluated the heart rate variability parameters in 50 patients with acute rheumatic fever and 37 comparable control subjects. Both groups underwent 24-hour electrocardiography monitoring, and time- and frequency-domain heart rate variability parameters were calculated. A total of 39 patients (78%), with (n = 28) or without (n = 11) other major findings, had carditis, and the remaining 11 (22%) did not. The PR interval was found to be prolonged in 10 (20%) of the patients at the beginning.

Results

In the study group, the time- and frequency-domain heart rate variability parameters showed a sympathetic dominance compared with the control group, with a p-value less than 0.05. When compared with the control group, the time- and frequency-domain heart rate variability parameters showed a significant sympathetic dominance in patients with both prolonged PR and normal PR intervals in the acute period, with a p-value less than 0.05. When compared with patients with normal PR interval, mean normalised low frequency and normalised high frequency parameters suggested a relatively lower sympathetic dominance in patients with prolonged PR interval, with a p-value less than 0.05.

Conclusion

Our results indicated that in the acute period of rheumatic fever, sympathetic dominance is apparent; in patients with prolonged PR interval, sympathetic dominance is relatively lower when compared with the patients with normal PR interval.

Type
Original Article
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Gerber, MA. Group A streptococcus. In: Nelson W, Behrman R, Kliegman RM, Jenson HB, Stanton BF (eds.). Nelson Textbook of Pediatrics. W.B. Saunders Company, Philadelphia, 2007, pp. 11351145.Google Scholar
2.Tani, LY. Rheumatic fever and rheumatic heart disease. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF (eds.). Moss and Adams Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adult, 7th edn. (Vol II). Lippincott Williams & Wilkins, Philadelphia, 2008, pp. 12561280.Google Scholar
3.Guidelines for the Diagnosis of Rheumatic Fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992; 268: 20692073.Google Scholar
4.Keith, JD. Overstimulation of the vagus nerve in rheumatic fever. Q J Med 1938; 7: 2942.Google Scholar
5.Guyton, AC, Hall, JE. The autonomic nervous system; and the adrenal medulla. In: Guyton AC, Hall JE (eds.). The Textbook of Medical Physiology. W.B. Saunders Company, Philadelphia, 2000, pp. 697708.Google Scholar
6.Task Force of The European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability-standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354381.CrossRefGoogle Scholar
7.Park, MK, Guntheroth, WG. (eds.). How to Read Pediatric Electrocardiography. Mosby Year Book, St. Louis, 1992, pp. 4255.Google Scholar
8.Bisno, A, Butchart, EG, Ganguly, NK, Ghebrehiwet, T, et al. Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser 2004; 923: 1122.Google Scholar
9.Clark, M, Keith, JD. Atrio ventricular conduction in acute rheumatic fever. Br Heart J 1972; 34: 472479.CrossRefGoogle Scholar
10.Karacan, M, Işıkay, S, Olgun, H, Ceviz, N. Asymptomatic rhythm and conduction abnormalities in children with acute rheumatic fever: 24-hour electrocardiography study. Cardiol Young 2010; 20: 620630.CrossRefGoogle ScholarPubMed
11.Guyton, AC, Hall, JE. Rhythmical excitation of the heart. In: Guyton AC, Hall JE (eds.). The Textbook of Medical Physiology. W.B. Saunders Company, Philadelphia, 2000, pp. 107113.Google Scholar
12.Silvetti, MS, Drago, F, Ragonese, P. Heart rate variability in healthy children and adolescents is partially related to age and gender. Int J Cardiol 2001; 81: 169174.CrossRefGoogle ScholarPubMed
13.Kardelen, F, Tezcan, G, Akcurin, G, Ertug, H, Yesilipek, A. Heart rate variability in patients with thalassemia major. Pediatr Cardiol 2008; 29: 935939.CrossRefGoogle ScholarPubMed
14.Ozdemir, O, Alyan, O, Soylu, M, et al. Sympathetic overactivity in patients with rheumatic mitral stenosis. Ann Noninvasive Electrocardiol 2004; 9: 352357.CrossRefGoogle ScholarPubMed
15.Dzimiri, N, Moorji, A, Kumar, N, Halees, Z. Effects of different left ventricular load conditions on myocardial beta-adrenoceptor density in patients with rheumatic heart valvular disease. Gen Pharmacol 1996; 27: 10191023.CrossRefGoogle ScholarPubMed